| Product Code: ETC12750955 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Sweden continues to source a significant volume of nimodipine imports from top exporters such as China, USA, Germany, Switzerland, and the UK. Despite a negative compound annual growth rate (CAGR) of -7.01% from 2020 to 2024, there was a notable growth rate of 5.2% from 2023 to 2024. The high Herfindahl-Hirschman Index (HHI) indicates a concentration of imports among these key exporting countries, highlighting the competitive landscape and market dynamics in the nimodipine import industry in Sweden.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Nimodipine Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Nimodipine Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Nimodipine Market - Industry Life Cycle |
3.4 Sweden Nimodipine Market - Porter's Five Forces |
3.5 Sweden Nimodipine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Sweden Nimodipine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Sweden Nimodipine Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.8 Sweden Nimodipine Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Sweden Nimodipine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in Sweden |
4.2.2 Growing awareness about the benefits of nimodipine in treating subarachnoid hemorrhage |
4.2.3 Technological advancements in drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval |
4.3.2 Competition from alternative treatment options |
4.3.3 Potential side effects associated with nimodipine use |
5 Sweden Nimodipine Market Trends |
6 Sweden Nimodipine Market, By Types |
6.1 Sweden Nimodipine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Nimodipine Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Sweden Nimodipine Market Revenues & Volume, By Immediate-Release, 2021 - 2031F |
6.1.4 Sweden Nimodipine Market Revenues & Volume, By Extended-Release, 2021 - 2031F |
6.1.5 Sweden Nimodipine Market Revenues & Volume, By Combination Drugs, 2021 - 2031F |
6.2 Sweden Nimodipine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Sweden Nimodipine Market Revenues & Volume, By Subarachnoid Hemorrhage, 2021 - 2031F |
6.2.3 Sweden Nimodipine Market Revenues & Volume, By Stroke Prevention, 2021 - 2031F |
6.2.4 Sweden Nimodipine Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3 Sweden Nimodipine Market, By Dosage Form |
6.3.1 Overview and Analysis |
6.3.2 Sweden Nimodipine Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.3.3 Sweden Nimodipine Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.3.4 Sweden Nimodipine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4 Sweden Nimodipine Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Sweden Nimodipine Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Sweden Nimodipine Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.4.4 Sweden Nimodipine Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
7 Sweden Nimodipine Market Import-Export Trade Statistics |
7.1 Sweden Nimodipine Market Export to Major Countries |
7.2 Sweden Nimodipine Market Imports from Major Countries |
8 Sweden Nimodipine Market Key Performance Indicators |
8.1 Number of clinical trials studying nimodipine efficacy and safety |
8.2 Adoption rate of nimodipine in Swedish hospitals and healthcare facilities |
8.3 Investment in research and development for nimodipine formulations |
9 Sweden Nimodipine Market - Opportunity Assessment |
9.1 Sweden Nimodipine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Sweden Nimodipine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Sweden Nimodipine Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.4 Sweden Nimodipine Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Sweden Nimodipine Market - Competitive Landscape |
10.1 Sweden Nimodipine Market Revenue Share, By Companies, 2024 |
10.2 Sweden Nimodipine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here